Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Lymphoma, T-Cell, Peripheral × Brentuximab Vedotin × Clear all

Phase

Phase 2 5 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma, T-Cell, Peripheral 1 Leukemia, Large Granular Lymphocytic 1

Interventions

calaspargase pegol 1 Prednisone 1 Methotrexate 1 Immunotherapy, Adoptive 1 Ifosfamide 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 CF regimen 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

New York Medical College

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡